Uncontrolled Hypertension Research Study

This clinical research study is evaluating the safety and effectiveness of an investigational medication (RTN-001) designed to help lower blood pressure. This medication works by helping blood vessels relax and improving blood flow, which may support healthier blood pressure levels throughout the day.

RTN-001 is a modified-release formulation, meaning it is designed to work over a prolonged period to provide more consistent blood pressure control.

Schedule of Activities 

• Total Clinic Visits: 9 clinic visits
• Total Study Duration: 18-19 weeks